Ayahuasca Research Portal

Topics:

21 results for “therapeutic potential”

Year:–

Open Access only

Showing 21 of 181 articles

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2026

Neuroimaging study

Neuroscience

DOI Resolved

Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease

Calleja-Conde J, Echeverry-Alzate V, Sanz-SanCristobal M et al.

Experimental neurology, 2026

Cross-sectional survey

Depression & Mood

DOI Resolved

Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish

Lodetti G, Inserra A, Redivo H et al.

Psychopharmacology, 2026

Clinical trial protocol

Depression & Mood

DOI Resolved

The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study

Camargos GS, de Faria Júnior GM, Lourenço M et al.

Frontiers in psychiatry, 2026

Open Access

Longitudinal observational

Clinical Trials

DOI Resolved

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Melani A, Papini G, Bonaso M et al.

Biomedicines, 2026

Open Access

Pharmacokinetic study

Psychology

PubMed Verified

Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: a randomized controlled trial in healthy subjects

Aicher HD, Wicki IA, Meling D et al.

Journal of Psychopharmacology, 2025

Open Access

Randomized controlled trial

Ayahuasca
Research Portal

Research Library

Filters

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study

Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease

Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish

The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: a randomized controlled trial in healthy subjects

Edo Maimon

Research Library

Filters

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study

Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease

Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish

The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study

Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind

Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: a randomized controlled trial in healthy subjects

Edo Maimon

Ayahuasca Research Digest